| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8953247 | European Urology Oncology | 2018 | 7 Pages |
Abstract
A large proportion of patients with prostate cancer on active surveillance are not in the lowest risk group. These patients have a higher risk of experiencing tumour progression to a stage requiring curative intervention. They also have worse disease prognosis compared to patients on active surveillance in the lowest risk group.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Timo F.W. Soeterik, Harm H.E van Melick, Lea M. Dijksman, Douwe H. Biesma, J. Alfred Witjes, Jean-Paul A. van Basten,